Management of Early-stage Triple-negative Breast Cancer during Pregnancy in the Immunotherapy Era: A Case Report and Review of Treatment Considerations
Journal of Young Women’s Breast Cancer and Health · 2026-01 · 3 (1) · 42-47
DOI: 10.4103/ywbc.ywbc_3_26 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Young Women’s Breast Cancer and Health, online erschienen am 18.06.2026. Verfasst von Lillian Sangha und 5 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Breast cancer diagnosed during pregnancy presents unique clinical challenges, particularly in the era of immunotherapy, which has become standard of care for early-stage triple-negative breast cancer (TNBC) in nonpregnant patients. However, immune checkpoint inhibitors are contraindicated during pregnancy due to limited safety data and potential fetal risk. We report the case of a pregnant young woman diagnosed with stage II TNBC who was successfully treated with anthracycline-and taxane-based chemotherapy without immunotherapy during pregnancy. Multidisciplinary coordination allowed continuation of curative-intent therapy while prioritizing fetal safety. This case highlights real-world deviations from guideline-based therapy necessitated by pregnancy, emphasizes multidisciplinary decision-making, and reviews considerations regarding postpartum management and breastfeeding.
Zitieren
APA
Sangha, L., Cherico, A. S., Bansal, V., Robinson, L., Silparshetty, S., & Polimera, H. V. (2026). Management of Early-stage Triple-negative Breast Cancer during Pregnancy in the Immunotherapy Era: A Case Report and Review of Treatment Considerations. Journal of Young Women’s Breast Cancer and Health, 3(1), 42-47. https://doi.org/10.4103/ywbc.ywbc_3_26
Vancouver
Sangha L, Cherico AS, Bansal V, Robinson L, Silparshetty S, Polimera HV. Management of Early-stage Triple-negative Breast Cancer during Pregnancy in the Immunotherapy Era: A Case Report and Review of Treatment Considerations. Journal of Young Women’s Breast Cancer and Health. 2026;3(1):42-47. doi:10.4103/ywbc.ywbc_3_26
BibTeX
@article{Sangha2026,
author = {Sangha, Lillian and Cherico, Adriani S and Bansal, Vasu and Robinson, Leila and Silparshetty, Saharsh and Polimera, Hyma V.},
title = {Management of Early-stage Triple-negative Breast Cancer during Pregnancy in the Immunotherapy Era: A Case Report and Review of Treatment Considerations},
journal = {Journal of Young Women’s Breast Cancer and Health},
year = {2026},
volume = {3},
number = {1},
pages = {42--47},
doi = {10.4103/ywbc.ywbc_3_26}
}
EUVIMED